Related Experiment Videos
Retrovirus-mediated IL-4 gene therapy in spontaneous adenocarcinomas from MMTV-neu transgenic mice
M Sacco1, S Benedetti, E M Catò
1Department of Human Genome and Multifactorial Diseases, Istituto di Tecnologie Biomediche Avanzate, CNR, Segrate (MI), Italy.
Abstract:
Gene therapy approaches to the treatment of experimental cancer are usually based on established neoplastic cell lines which are manipulated in vitro and subsequently transplanted in host animals. However, the relevance of these artificial models to the biology and therapy of human tumors is uncertain. We have previously validated an experimental model based on MMTV-neu transgenic mice in which breast tumors arise spontaneously in 100% of animals and have many features in common with their human counterpart, including the involvement of the neu oncogene and the ability to metastatize. In this article we report the effect of intratumoral, retrovirus-mediated, IL-4 expression on the growth of breast tumors arising in these mice. The size of IL-4 inoculated tumors on the right side was significantly smaller than that of controlateral untreated tumors, suggesting a local effect of IL-4. In addition, the non-injected tumors on the left side of treated animals were significantly smaller than those arising in control transgenic mice, suggesting that IL-4 can also inhibit tumor growth systemically. These findings suggest that IL-4 gene transfer can significantly reduce the growth rate of spontaneously arising breast tumors and that immune-based gene therapy could efficiently complement other approaches based on different mechanisms, such as suicide gene transfer or antisense technology.
Insights
Gene therapy using interleukin-4 (IL-4) effectively reduced breast tumor growth in mice. This immune-based approach showed both local and systemic anti-tumor effects, offering a promising complement to other cancer treatments.
Area of Science:
- Oncology
- Immunotherapy
- Gene Therapy
Background:
- Traditional cancer gene therapy models lack human tumor relevance.
- Spontaneous MMTV-neu transgenic mouse model closely mimics human breast cancer, including metastasis.
- This model involves the neu oncogene, a key factor in many human breast cancers.
Purpose of the Study:
- To investigate the effect of intratumoral, retrovirus-mediated interleukin-4 (IL-4) expression on spontaneous breast tumor growth in MMTV-neu transgenic mice.
- To assess both local and systemic anti-tumor effects of IL-4 gene transfer.
Main Methods:
- Utilized MMTV-neu transgenic mice with spontaneously arising breast tumors.
- Administered retrovirus-mediated IL-4 gene transfer intratumorally.
- Compared tumor growth in treated mice versus control groups.
Main Results:
- IL-4 inoculated tumors showed significantly reduced size compared to untreated contralateral tumors, indicating a local effect.
- Non-injected tumors in treated mice were also significantly smaller than tumors in control mice, suggesting systemic inhibition.
- IL-4 gene transfer significantly reduced the growth rate of spontaneously arising breast tumors.
Conclusions:
- Intratumoral IL-4 gene transfer demonstrates significant efficacy in reducing spontaneous breast tumor growth.
- IL-4 mediated immune-based gene therapy can effectively complement other cancer treatment strategies.
- This approach holds promise for enhancing breast cancer treatment paradigms.